Although further investigations of the precise mechanism by which higher Capn4 expression correlates with a poorer ICC prognosis are still in process, we consider our results to be significant, and Capn4 may be used as a molecular therapeutic target for ICC. Here, CAPNS1 is linked to intrahepatic cholangiocarcinoma.